Simultaneous Application of Bone Morphogenetic Protein-2 and Platelet-Rich Fibrin for the Treatment of Bisphosphonate-Related Osteonecrosis of Jaw

J Oral Implantol. 2016 Apr;42(2):205-8. doi: 10.1563/aaid-joi-D-14-00309. Epub 2015 Jun 23.
No abstract available

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / therapy
  • Bone Density Conservation Agents* / adverse effects
  • Diphosphonates
  • Humans
  • Platelet-Rich Fibrin*

Substances

  • Bone Density Conservation Agents
  • Diphosphonates